Irritant patch test reactions to cosmetic ingredients

IF 0.2 Q4 ALLERGY
Jadwiga Kalicińska, B. Wiśniowska, R. Spiewak
{"title":"Irritant patch test reactions to cosmetic ingredients","authors":"Jadwiga Kalicińska, B. Wiśniowska, R. Spiewak","doi":"10.5114/pja.2022.112784","DOIUrl":null,"url":null,"abstract":"Introduction: The use of cosmetics and skin care products is on a steady increase, especially in developed countries. Despite increasingly strict regulations, ingredients with irritant potential are still widely used in cosmetic products. On patch tests, irritant reactions may be mistaken for allergic reactions, leading to mis-diagnoses. Aim: To compile and analyze available data on irritant reactions to cosmetic ingredients from patch test studies in humans. Material and methods: Data on irritant reactions to cosmetic ingredients in patch tests were extracted from published patch test studies indexed in PubMed, Embase, Web of Science or Google Scholar. The available data were pooled to assess the frequency and create a ranking list of irritant cosmetic ingredients. Results: Data on the prevalence of irritant reactions among people undergoing patch testing (routine or experimental) were available for 47 cosmetic ingredients. Among ingredients routinely tested in the European Baseline Series, the highest rates of irritant reactions were reported for Myroxylon pereirae resin (balsam of Peru, irritant reactions in 3.40% of patch test patients), followed by Fragrance mix II (2.83%), Fragrance mix I (2.34%), colophonium (1.14%), p-phenylenediamine 1% (0.99%), hydroxyisohexyl 3-cyclohexene carboxal-dehyde (0.70%), Paraben mix (0.48%) and Quaternium 15 (0.29%). Conclusions: A range of widely used cosmetic ingredients possess irritative properties, which may contribute to irritant contact dermatitis in the consumers. In routine patch testing, irritant reactions to cosmetic ingredients may emerge in as many as one in ten patients. As irritant reactions to cosmetic ingredients in patch tests may contribute to false diagnosis of allergic contact dermatitis, doctors should be aware of the risk and able to single out such reactions.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alergologia Polska - Polish Journal of Allergology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/pja.2022.112784","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: The use of cosmetics and skin care products is on a steady increase, especially in developed countries. Despite increasingly strict regulations, ingredients with irritant potential are still widely used in cosmetic products. On patch tests, irritant reactions may be mistaken for allergic reactions, leading to mis-diagnoses. Aim: To compile and analyze available data on irritant reactions to cosmetic ingredients from patch test studies in humans. Material and methods: Data on irritant reactions to cosmetic ingredients in patch tests were extracted from published patch test studies indexed in PubMed, Embase, Web of Science or Google Scholar. The available data were pooled to assess the frequency and create a ranking list of irritant cosmetic ingredients. Results: Data on the prevalence of irritant reactions among people undergoing patch testing (routine or experimental) were available for 47 cosmetic ingredients. Among ingredients routinely tested in the European Baseline Series, the highest rates of irritant reactions were reported for Myroxylon pereirae resin (balsam of Peru, irritant reactions in 3.40% of patch test patients), followed by Fragrance mix II (2.83%), Fragrance mix I (2.34%), colophonium (1.14%), p-phenylenediamine 1% (0.99%), hydroxyisohexyl 3-cyclohexene carboxal-dehyde (0.70%), Paraben mix (0.48%) and Quaternium 15 (0.29%). Conclusions: A range of widely used cosmetic ingredients possess irritative properties, which may contribute to irritant contact dermatitis in the consumers. In routine patch testing, irritant reactions to cosmetic ingredients may emerge in as many as one in ten patients. As irritant reactions to cosmetic ingredients in patch tests may contribute to false diagnosis of allergic contact dermatitis, doctors should be aware of the risk and able to single out such reactions.
对化妆品成分的刺激性斑贴试验反应
化妆品和护肤品的使用正在稳步增长,尤其是在发达国家。尽管法规越来越严格,但具有潜在刺激性的成分仍广泛应用于化妆品中。在斑贴试验中,刺激性反应可能被误认为过敏反应,从而导致误诊。目的:收集和分析人类对化妆品成分的过敏反应的可用数据。材料和方法:有关斑贴试验中化妆品成分的刺激性反应的数据摘自PubMed、Embase、Web of Science或谷歌Scholar检索的已发表的斑贴试验研究。可用的数据被汇总以评估频率并创建一个刺激性化妆品成分的排名列表。结果:在进行补丁测试(常规或实验性)的人群中,有47种化妆品成分的刺激性反应发生率的数据。在欧洲基线系列常规检测的成分中,报告的刺激反应率最高的是Myroxylon pereirae树脂(秘鲁香脂,在3.40%的斑贴试验患者中有刺激反应),其次是香精混合物II(2.83%)、香精混合物I(2.34%)、树脂(1.14%)、对苯二胺1%(0.99%)、羟基异己基3-环己烯甲醛(0.70%)、对羟基苯甲酸酯混合物(0.48%)和季铵盐15(0.29%)。结论:一系列广泛使用的化妆品成分具有刺激性,这可能导致消费者的刺激性接触性皮炎。在常规的补丁测试中,对化妆品成分的刺激性反应可能会出现在多达十分之一的患者中。由于在斑贴试验中对化妆品成分的刺激性反应可能导致过敏性接触性皮炎的错误诊断,医生应该意识到这种风险,并能够挑出这种反应。【关键词】化妆品成分;刺激电位;斑贴试验;教授Radosław Śpiewak,雅盖隆大学医学院实验皮肤美容学系,ul。mediyczna 9, 30-688克拉科夫,波兰,电话:+48 12 620 58 30,电子邮件:radoslaw.spiewak@uj.edu.pl
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
50.00%
发文量
18
期刊介绍: Alergologia Polska - Polish Journal of Allergology is aimed mainly at allergologists, but also medical doctors working in related fields, such as otolaryngology, pulmonology, and dermatology. The main goal of the journal is to ensure rapid publication of important research papers and interesting case studies from the following areas: allergology, diagnostics, therapy of allergic diseases, in particular in the area of immunotherapy, rhinitis, asthma. The Editorial Board accepts for publication original papers, case studies and letters to the Editor. We also publish review articles (both commissioned and those agreed upon with the Editor-in-Chief), articles dealing with standards of medical practice, as well as special issues. The journal is published quarterly. We guarantee short review times (up to two weeks) and immediate publication on-line upon Editor acceptance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信